Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60

被引:84
作者
Quintana, FJ [1 ]
Carmi, P [1 ]
Mor, F [1 ]
Cohen, IR [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
关键词
D O I
10.4049/jimmunol.169.6.3422
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Adjuvant arthritis (AA) is an autoimmune disease inducible in rats involving T cell reactivity to the mycobacterial 65-kDa heat shock protein (HSP65). HSP65-specific T cells cross-reactive with the mammalian 60-kDa heat shock protein (HSP60) are thought to participate in the modulation of AA. In this work we studied the effects on AA of DNA vaccination using constructs coding for HSP65 (pHSP65) or human HSP60 (pHSP60). We found that both constructs could inhibit AA, but that pHSP60 was more effective than pHSP65. The immune effects associated with specific DNA-induced suppression of AA were complex and included enhanced T cell proliferation to a variety of disease-associated Ags. Effective vaccination with HSP60 or HSP65 DNA led paradoxically to up-regulation of IFN-gamma secretion to HSP60 and, concomitantly, to down-regulation of IFN-gamma secretion to the P180-188 epitope of HSP65. There were also variable changes in the profiles of IL-10 secretion to different Ags. However, vaccination with pHSP60 or pHSP65 enhanced the production of TGFbeta1 to both HSP60 and HSP65 epitopes. Our results support a regulatory role for HSP60 autoreactivity in AA and demonstrate that this control mechanism can be activated by DNA vaccination with both HSP60 or HSP65.
引用
收藏
页码:3422 / 3428
页数:7
相关论文
共 44 条
[1]  
ANDERTON SM, 1994, J IMMUNOL, V152, P3656
[2]   ACTIVATION OF T-CELLS RECOGNIZING SELF 60-KD HEAT-SHOCK PROTEIN CAN PROTECT AGAINST EXPERIMENTAL ARTHRITIS [J].
ANDERTON, SM ;
VANDERZEE, R ;
PRAKKEN, B ;
NOORDZIJ, A ;
VANEDEN, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :943-952
[3]   2 MONOCLONAL-ANTIBODIES GENERATED AGAINST HUMAN HSP60 SHOW REACTIVITY WITH SYNOVIAL MEMBRANES OF PATIENTS WITH JUVENILE CHRONIC ARTHRITIS [J].
BOOG, CJP ;
DEGRAEFFMEEDER, ER ;
LUCASSEN, MA ;
VANDERZEE, R ;
VOORHORSTOGINK, MM ;
VANKOOTEN, PJS ;
GEUZE, HJ ;
VANEDEN, W .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (06) :1805-1810
[4]   Immunohistochemical study of lymphoid tissues in adjuvant arthritis (AA) by image analysis;: relationship with synovial lesions [J].
Carol, M ;
Pelegrí, C ;
Castellote, C ;
Franch, A ;
Castell, M .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (01) :200-208
[5]  
Chastain M, 2001, J PHARM SCI, V90, P474, DOI 10.1002/1520-6017(200104)90:4<474::AID-JPS1005>3.0.CO
[6]  
2-6
[7]   Pathogenic lymphoid cells engineered to express TGF beta 1 ameliorate disease in a collagen-induced arthritis model [J].
Chernajovsky, Y ;
Adams, G ;
Triantaphyllopoulos, K ;
Ledda, MF ;
Podhajcer, OL .
GENE THERAPY, 1997, 4 (06) :553-559
[8]  
Cohen I. R., 2000, TENDING ADAMS GARDEN, DOI DOI 10.1016/B978-012178355-6/50030-5
[9]   Discrimination and dialogue in the immune system [J].
Cohen, IR .
SEMINARS IN IMMUNOLOGY, 2000, 12 (03) :215-219
[10]   T regulatory cells 1 inhibit a Th2-specific response in vivo [J].
Cottrez, F ;
Hurst, SD ;
Coffman, RL ;
Groux, H .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :4848-4853